Application of principal component regression at the U.S. Transuranium and Uranium Registries
On Monday September 19th at 4pm in Olin 201 Martin Šefl will talk about the method of principle component analysis (PCA) in the context of regression on data from the United States Transuranium and Uranium Registries (USTUR).
The United States Transuranium and
Uranium Registries (USTUR) studies actinide (Pu, Am, and U) biokinetics and
tissue dosimetry by following up former nuclear workers with documented
internal deposition of these radioactive elements. The USTUR research relies
heavily upon postmortem autopsy findings and radiochemical analyses of donated
tissues. Plutonium is a radioactive element first produced and isolated in the
1940s. The skeleton is a major plutonium retention site in the human body. The
estimation of the total plutonium activity in the skeleton is a challenging
problem. For most tissue donors at the USTUR, a limited number of bone samples
is available. Typically, the total skeleton activity is calculated using
plutonium activity concentration (Cskel) and skeleton weight.
If limited number of bone samples was analyzed, Cskel could
be estimated using multiple linear regression (MLR) of data from whole-body
donors, where Cskel were estimated based on the analysis of
the half of the skeleton. The caveat of MLR is that individual bone sample
concentrations are correlated. Multicollinearity can be addressed by principal
component regression (PCR). PCR consist of two steps, PCA and regression. PCA enables to reduce the number of variables
for regression while retaining information. A brief introduction into PCR and
its application of PCR for estimates of plutonium concentration in the skeleton
will be discussed.
BIO: Martin Šefl is a Post-doctoral Research Associate at the United States Transuranium and Uranium Registries, College of Pharmacy and Pharmaceutical Sciences, Washington State University. His research is focused on biokinetic modeling and radiation dose calculations of plutonium internally deposited in the human body. Dr. Šefl holds a PhD degree in Radiological Physics from the Czech Technical University in Prague. His doctoral research was focused on the cellular radiation dosimetry calculations using Geant4 Monte Carlo code. He worked as a medical physicist in the department of radiation oncology in a hospital in Prague.
Comments
Post a Comment